Opioid Use Disorder Statistics in Vermont

Comprehensive Opioid Use Disorder statistics for Vermont, including prevalence, demographics, treatment access, and outcomes data.

2 min read
38.2[1]
Opioid-Related Fatal Overdoses per 100,000 Residents

This rate highlights the severe mortality impact of the opioid crisis in Vermont.

2025

Key Takeaways

  • Vermont's fatal opioid overdose rate is nearly 60% higher than the national average, indicating a disproportionately severe crisis in the state.59.2% Higher[1]
  • The crisis is overwhelmingly driven by illicit synthetic opioids like fentanyl, which are involved in nearly 95% of all opioid-related fatalities in Vermont.94.8%[1]
  • A significant treatment gap persists, with nearly 75% of Vermonters who need treatment for a substance use disorder not receiving timely care.74.86%[2]
  • Young adults aged 18-25 are disproportionately affected, with an OUD prevalence of 4%, compared to 3% among those over 25.4.0%[3]
  • Access to evidence-based care is limited; only about 60% of individuals with OUD in Vermont are able to access treatments like medication-assisted treatment (MAT).60%[3]
  • A shortage of specialized providers exists, with Vermont averaging 5 OUD treatment providers per 100,000 residents, below the national average of 8.5 per 100k[3]
  • The crisis impacts the state's youngest residents, with 61.4 out of every 1,000 infants born in 2020 diagnosed with neonatal opioid withdrawal syndrome.61.4 per 1,000[1]

The Scale of Opioid Use Disorder in Vermont

Opioid Use Disorder (OUD) represents a significant public health challenge in Vermont and across the nation. Nationally, an estimated 1.6 million people aged 12 or older met the criteria for OUD in 2021[4]. This is part of a broader landscape of substance use disorders (SUDs), which affected nearly 48.5 million Americans in the past year[5]. Understanding the specific prevalence and impact within Vermont is crucial for developing effective, targeted public health strategies.

Prevalence at a Glance

2.4%[3]
Of Vermont adults had OUD in the past year

Based on 2022-2023 NSDUH data.

2022-2023
89.6%[1]
Of all overdose deaths in Vermont involved opioids

Shows the dominant role of opioids in fatal overdose events.

2023
7.8%[1]
Of overdose deaths involved prescription opioids

Indicates the crisis has shifted from prescription misuse to illicit substances.

2023
20.3%[6]
Of Vermonters experienced any mental illness

Highlights the common co-occurrence of mental health conditions with SUDs.

2022

Demographics and Disparities

Opioid Use Disorder does not affect all populations equally. Factors such as age, gender, geography, and socioeconomic status play a significant role in both prevalence and outcomes. In Vermont, data reveals that early onset of OUD is correlated with more severe long-term health problems[3]. Furthermore, rural isolation and socioeconomic stressors contribute to an environment where illicit drug markets can thrive[1], and certain counties like Chittenden and Windham report higher rates of emergency department visits for overdoses[1].

National Gender and Racial Disparities

National data reveals stark disparities in opioid overdose fatalities by gender and race. Men are significantly more likely to die from an opioid overdose than women. Racially, non-Hispanic white individuals have historically comprised a majority of opioid overdose deaths, though rates have been rising rapidly in other communities. These national trends provide important context for understanding the demographic risk factors associated with the opioid crisis.[8]

Opioid Overdose Death Rate (per 100,000)
24
Men
13
Women
Men died at nearly twice the rate of women
According to 2020 CDC data, men experienced a significantly higher mortality rate from opioid overdoses nationally.

Treatment and Access to Care

Access to timely and effective treatment is the most critical factor in reducing overdose deaths and helping individuals achieve recovery. Vermont has implemented progressive Medicaid policies to expand coverage for OUD interventions[4]. However, significant barriers remain, including stigma, socioeconomic constraints, and provider shortages, which continue to impede universal access to care[9]. Low rates of treatment uptake mean that the majority of individuals with OUD are not accessing evidence-based interventions that can reduce mortality[10].

The Treatment Landscape

65%[4]
Of diagnosed individuals in VT engaged in treatment

Represents the proportion of those with a formal OUD diagnosis who are connected to a treatment program.

2022
32%[11]
Of individuals with OUD received MAT nationally

Medication-assisted treatment (MAT) is a key evidence-based practice for OUD.

2021
84.17%[2]
Of young adults in VT needing SUD treatment do not get it

This highlights a particularly large and concerning treatment gap among a high-risk population.

Active substance use treatment facilities in Vermont

The total number of facilities providing services for substance use disorders in the state.

Please note that statistics on prevalence, treatment, and mortality can vary between sources like the CDC, SAMHSA, and the Vermont Department of Health. These differences may be due to different data collection periods, survey methodologies, or whether data is preliminary or final.

Frequently Asked Questions

Sources & References

All statistics and claims on this page are supported by peer-reviewed research and official government data sources.

1Opioid Overdose Dashboard | Vermont Department of Health. Healthvermont. Published 2025. Accessed January 2026. https://www.healthvermont.gov/stats/data-reporting-topic/opioid-overdose-dashboard
2Vermont Drug and Alcohol Statistics - Methadone.org. Methadone. Accessed January 2026. https://www.methadone.org/drugs/vermont-drug-alcohol-statistics/
3[PDF] Vermont 2022 2023 NSDUH. Healthvermont. Accessed January 2026. https://www.healthvermont.gov/sites/default/files/document/dsu-vt-nsduh-2022-2023.pdf
4[PDF] Behavioral Health Barometer: Vermont, Volume 6 - SAMHSA. Substance Abuse and Mental Health Services Administration. Published 2017. Accessed January 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt32862/Vermont-BH-Barometer_Volume6.pdf
5Key Substance Use and Mental Health Indicators in the United States. Substance Abuse and Mental Health Services Administration. Published 2023. Accessed January 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt47095/National%20Report/National%20Report/2023-nsduh-annual-national.htm
6Prevalence of Select Mental Health Diagnoses among .... Uvm. Published 2022. Accessed January 2026. https://www.uvm.edu/d10-files/documents/2025-02/VCHIP_R-E_data_brief_MH_prevalence_2022.pdf
7Caledonia C. Opioid Overdose Dashboard | Vermont Department of Health. Healthvermont. Accessed January 2026. https://www.healthvermont.gov/stats/data-reporting-topic/opioid-overdose-dashboard
8Opioid Crisis Statistics [2025]: Prescription Opiod Abuse. Drugabusestatistics. Accessed January 2026. https://drugabusestatistics.org/opioid-epidemic/
9In V. Decreasing Incident Opioid Use Disorder, Especially Adolescent .... ScienceDirect. Published 2017. Accessed January 2026. https://www.sciencedirect.com/science/article/abs/pii/S0749379724004197
10Has the treatment gap for opioid use disorder narrowed in the U.S.?. ScienceDirect. Accessed January 2026. https://www.sciencedirect.com/science/article/pii/S0955395922002031
11The Opioid Epidemic in Rural Northern New England - NIH. PubMed Central. Published 2016. PMC6879818. Accessed January 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC6879818/
12Data and Reports | Vermont Department of Health. Healthvermont. Accessed January 2026. https://www.healthvermont.gov/alcohol-drugs/substance-use-data-reports/data-and-reports
13[PDF] The State of the Opioid Crisis in Vermont Today. Uvm. Published 2020. Accessed January 2026. https://www.uvm.edu/d10-files/documents/2024-06/The-State-of-the-Opiate-Crisis-in-Vermont.pdf
14Impact of Medication-Assisted Treatment for Opioid Addiction on .... ScienceDirect. Published 2012. Accessed January 2026. https://www.sciencedirect.com/science/article/pii/S0740547215300659